Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
10/20/25 19:49 | 10/17/25 | GH | Health | Health | Medical Laboratories | Tariq Musa | CA | D | 12 | S.d | -296 | 44.18 | 0 | -7 | 8 | D | ||||||||||||||||
10/20/25 19:48 | 8/19/25 | GH | Health | Health | Medical Laboratories | Potter Myrtle S | CA | D | 6 | S.d | -138 | 49.99 | 0 | -3 | 18 | D | ||||||||||||||||
9/15/25 17:09 | 9/12/25 | GH | Health | Health | Medical Laboratories | Hidalgo Medina Manuel | CA | D | 1 | S | -117 | 54.16 | 0 | -2 | 1 | D | ||||||||||||||||
9/11/25 19:14 | 9/9/25 | GH | Health | Health | Medical Laboratories | Eltoukhy Helmy | CA | DO | Co-CEO | 1 | S | -17,836 | 59.45 | 0 | -300 | 2,123 | D | |||||||||||||||
9/3/25 18:50 | 9/2/25 | GH | Health | Health | Medical Laboratories | Joyce Meghan V. | CA | D | 6 | S.d | -263 | 39.62 | 0 | -7 | 11 | D | ||||||||||||||||
8/22/25 16:58 | 8/21/25 | GH | Health | Health | Medical Laboratories | Kalia Kumud | CA | O | CIO | 4 | S.d | -665 | 40.29 | 0 | -17 | 20 | D | |||||||||||||||
7/2/25 21:18 | 7/1/25 | GH | Health | Health | Medical Laboratories | Talasaz Amirali | CA | DO | Co-CEO | 3 | S.dm | -16,999 | 50.00 | 0 | -340 | 2,189 | D | |||||||||||||||
6/20/25 17:26 | 6/17/25 | GH | Health | Health | Medical Laboratories | Clark Ian T | CA | D | 2 | S.d | -568 | 37.88 | 0 | -15 | 10 | I |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |